Annis Gardner Whiting Capital Advisors, LLC Moderna, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $485 Billion
- Q3 2025
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 11,651 shares of MRNA stock, worth $288,478. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,651
Previous 10,654
9.36%
Holding current value
$288,478
Previous $294 Million
2.38%
% of portfolio
0.06%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
843Shares Held
257MCall Options Held
39.6MPut Options Held
43.1M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$541 Million0.44% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...